Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1986-12-30
|
pubmed:abstractText |
Vecuronium was administered as an intravenous bolus (50 micrograms kg-1) to 10 normal and 10 anephric patients. The elimination half-life was 50.7 +/- 20.3 min in normal patients and 67.826.3 min in anephric patients. The plasma clearance was 3.6 +/- 1.5 ml min-1 for normal patients and 4.5 +/- 2.6 ml min-1 kg-1 for anephric patients. Only the volume of the second compartment was statistically increased (+90%, P less than 0.05) in anephric patients. The duration of action in normal patients (25.3 +/- 9.8 min) was comparable to the duration of action in patients with renal failure (32.8 +/- 10.7 min), but the recovery index was prolonged (+45%, P less than 0.05) in anephric patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0265-0215
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
153-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2877876-Adult,
pubmed-meshheading:2877876-Half-Life,
pubmed-meshheading:2877876-Humans,
pubmed-meshheading:2877876-Kidney,
pubmed-meshheading:2877876-Kidney Failure, Chronic,
pubmed-meshheading:2877876-Metabolic Clearance Rate,
pubmed-meshheading:2877876-Middle Aged,
pubmed-meshheading:2877876-Time Factors,
pubmed-meshheading:2877876-Vecuronium Bromide
|
pubmed:year |
1986
|
pubmed:articleTitle |
Pharmacology of vecuronium in patients with end-stage renal failure.
|
pubmed:publicationType |
Journal Article
|